Tenax Therapeutics (TENX) Receivables (2011 - 2018)
Tenax Therapeutics (TENX) reported Receivables of $39286.0 for Q2 2018, up 59.38% on a YoY basis from $24649.0 in Q2 2017, and little changed sequentially from $39286.0 in Q1 2018.
Tenax Therapeutics (TENX) Receivables (2011 - 2018) Analysis & Trends
Tenax Therapeutics (TENX) has 8 years of Receivables data on file, last reported at $39286.0 in Q2 2018.
- For the quarter ending Q2 2018, Receivables rose 59.38% year-over-year to $39286.0; the trailing twelve-month figure through Jun 2018 stood at $39286.0 (up 59.38% YoY), and the FY2017 full-year result was $50171.0, down 30.89% from the prior year.
- Receivables held at $39286.0 in Q2 2018, from $39286.0 in the prior quarter.
- In the past five years, Receivables ranged from a high of $113184.0 in Q1 2014 to a low of $24648.0 in Q2 2016.
- A 5-year average of $49894.9 and a median of $44291.5 in 2016 frame the typical range for Receivables.
- Across the five-year window, Receivables slumped 96.15% in 2014 and jumped 110.34% in 2015, its largest moves.
- Tracing TENX's Receivables over 5 years: stood at $36358.0 in 2014, then surged by 36.0% to $49448.0 in 2015, then soared by 46.82% to $72599.0 in 2016, then tumbled by 30.89% to $50171.0 in 2017, then decreased by 21.7% to $39286.0 in 2018.
- Business Quant data shows TENX's Receivables at $39286.0 in Q2 2018, $39286.0 in Q1 2018, and $50171.0 in Q4 2017.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 4.97 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 938.02 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 1.13 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 2.00 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 5.73 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.93 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Tenax Therapeutics | 67,856.40 | 67,856.40 | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2018 | 39,286.00 |
| Mar 31, 2018 | 39,286.00 |
| Dec 31, 2017 | 50,171.00 |
| Sep 30, 2017 | 24,649.00 |
| Jun 30, 2017 | 24,649.00 |
| Mar 31, 2017 | 24,649.00 |
| Dec 31, 2016 | 72,599.00 |
| Sep 30, 2016 | 72,600.00 |
| Jun 30, 2016 | 24,648.00 |
| Mar 31, 2016 | 49,297.00 |
| Dec 31, 2015 | 49,448.00 |
| Apr 30, 2015 | 76,475.00 |
| Jan 31, 2015 | 64,662.00 |
| Jul 31, 2014 | 36,358.00 |
| Apr 30, 2014 | 36,358.00 |
| Jan 31, 2014 | 113,184.00 |
| Oct 31, 2013 | 59,058.00 |
| Jul 31, 2013 | 23,789.00 |
| Apr 30, 2013 | 945,237.00 |
| Jan 31, 2013 | 116,329.00 |